通化萬通藥業股份有限公司是吉林萬通藥業集團總部所在地，是集藥品生產、研發、銷售于一體的大型現代化、高科技企業。多年來，通化萬通藥業(ye)秉承(cheng)“造好(hao)藥，為人民”的企(qi)業(ye)核心理(li)念，堅(jian)持(chi)管理(li)創(chuang)(chuang)(chuang)新、產(chan)品創(chuang)(chuang)(chuang)新、營銷創(chuang)(chuang)(chuang)新和芒果视频創(chuang)(chuang)(chuang)新，使企(qi)業(ye)發(fa)展(zhan)迅速，成果顯著。

公(gong)司擁有8個(ge)獨家(jia)品(pin)種(zhong)為(wei)重要支撐的(de)100多個(ge)產品(pin)系(xi)列(lie)。經過(guo)多年(nian)的(de)培育(yu)，萬(wan)(wan)通(tong)產品(pin)以可(ke)靠的(de)質量和確切的(de)療效(xiao)暢銷(xiao)國內外(wai)，成為(wei)家(jia)喻戶曉的(de)知名品(pin)牌(pai)。公(gong)司致力(li)于(yu)打造(zao)全國風濕(shi)用藥第一(yi)品(pin)牌(pai)，以“萬(wan)(wan)通(tong)筋骨(gu)片”、“萬(wan)(wan)通(tong)筋骨(gu)貼”、“萬(wan)(wan)通(tong)筋骨(gu)噴劑(ji)”、“傷濕(shi)止(zhi)痛膏”等系(xi)列(lie)產品(pin)彰(zhang)顯品(pin)牌(pai)優(you)勢(shi)，特別是主打產品(pin)“萬(wan)(wan)通(tong)筋骨(gu)片”連續多年(nian)在(zai)全國同(tong)(tong)類、同(tong)(tong)劑(ji)型藥品(pin)中銷(xiao)量居于(yu)前列(lie)。

吉(ji)林(lin)萬(wan)通(tong)(tong)集(ji)(ji)團(tuan)(tuan)歷(li)經22年(nian)的(de)發展，現(xian)已成(cheng)為(wei)集(ji)(ji)醫(yi)藥(yao)生(sheng)產(chan)(chan)(chan)(chan)、研(yan)發、銷售(shou)為(wei)一體的(de)大型現(xian)代化實(shi)業(ye)集(ji)(ji)團(tuan)(tuan)。經過多年(nian)的(de)發展，現(xian)擁有三大板(ban)塊產(chan)(chan)(chan)(chan)業(ye)。第(di)一板(ban)塊為(wei)醫(yi)藥(yao)產(chan)(chan)(chan)(chan)業(ye)，是以通(tong)(tong)化萬(wan)通(tong)(tong)藥(yao)業(ye)股(gu)份有限(xian)公(gong)司(si)為(wei)母公(gong)司(si)，全資(zi)或(huo)控股(gu)子(zi)公(gong)司(si)有梅(mei)河萬(wan)通(tong)(tong)藥(yao)業(ye)、吉(ji)林(lin)萬(wan)通(tong)(tong)藥(yao)業(ye)、鄭州萬(wan)通(tong)(tong)復升藥(yao)業(ye)共4戶(hu)(hu)制藥(yao)企(qi)業(ye)和2戶(hu)(hu)參業(ye)種植(zhi)公(gong)司(si)，及萬(wan)通(tong)(tong)藥(yao)品經銷公(gong)司(si)1戶(hu)(hu)藥(yao)品經銷企(qi)業(ye)等。第(di)二(er)板(ban)塊為(wei)多元產(chan)(chan)(chan)(chan)業(ye)，擁有萬(wan)通(tong)(tong)葡萄酒股(gu)份公(gong)司(si)、萬(wan)通(tong)(tong)盛泰生(sheng)物工程(cheng)公(gong)司(si)、清水麗人化妝品公(gong)司(si)等多戶(hu)(hu)企(qi)業(ye)。第(di)三板(ban)塊為(wei)能(neng)源產(chan)(chan)(chan)(chan)業(ye)，萬(wan)邦礦(kuang)業(ye)集(ji)(ji)團(tuan)(tuan)下(xia)屬11戶(hu)(hu)礦(kuang)業(ye)企(qi)業(ye)。集(ji)(ji)團(tuan)(tuan)總(zong)部坐(zuo)落于(yu)吉(ji)林(lin)省通(tong)(tong)化市(shi)。集(ji)(ji)團(tuan)(tuan)以醫(yi)藥(yao)產(chan)(chan)(chan)(chan)業(ye)為(wei)主導產(chan)(chan)(chan)(chan)業(ye)，各產(chan)(chan)(chan)(chan)業(ye)之間相互促進，協調發展。集(ji)(ji)團(tuan)(tuan)始建于(yu)1997年(nian)11月18日，前身(shen)是通(tong)(tong)化市(shi)國有第(di)二(er)制藥(yao)廠。

為(wei)(wei)(wei)(wei)實現每個萬(wan)(wan)通(tong)(tong)人心中(zhong)的(de)萬(wan)(wan)通(tong)(tong)夢，面(mian)向未來(lai)，萬(wan)(wan)通(tong)(tong)集團將(jiang)以“轉(zhuan)型(xing)升級(ji)，創(chuang)(chuang)(chuang)新(xin)發(fa)展(zhan)”為(wei)(wei)(wei)(wei)戰略指(zhi)導(dao)思想，以深化(hua)供給側結構性改(gai)革為(wei)(wei)(wei)(wei)引(yin)導(dao)，堅持以市場營銷(xiao)(xiao)為(wei)(wei)(wei)(wei)龍頭，以追求高質量(liang)發(fa)展(zhan)為(wei)(wei)(wei)(wei)主線，以保證產(chan)品質量(liang)安全生產(chan)為(wei)(wei)(wei)(wei)根(gen)本，以實施(shi)科(ke)技(ji)(ji)創(chuang)(chuang)(chuang)新(xin)為(wei)(wei)(wei)(wei)動力，進軍大健(jian)康產(chan)業(ye)。通(tong)(tong)過新(xin)建(jian)萬(wan)(wan)通(tong)(tong)醫藥(yao)科(ke)技(ji)(ji)研(yan)發(fa)服務平臺(tai)，通(tong)(tong)過資(zi)本規(gui)模加創(chuang)(chuang)(chuang)新(xin)研(yan)發(fa)的(de)雙(shuang)輪驅動，做好中(zhong)藥(yao)產(chan)品的(de)二次開發(fa)；按國家的(de)要求推進化(hua)藥(yao)一(yi)致(zhi)性評價(jia)；布局化(hua)藥(yao)仿制藥(yao)的(de)研(yan)發(fa)；推進創(chuang)(chuang)(chuang)新(xin)藥(yao)的(de)研(yan)發(fa)。萬(wan)(wan)通(tong)(tong)集團決定，每年將(jiang)投(tou)入1.5-2億元用于新(xin)藥(yao)研(yan)發(fa)，為(wei)(wei)(wei)(wei)未來(lai)銷(xiao)(xiao)售力的(de)拉(la)動提供強大的(de)產(chan)品力支撐。集團將(jiang)持續(xu)秉(bing)承“造(zao)好藥(yao)，為(wei)(wei)(wei)(wei)人民”的(de)核心理念，擼起袖子(zi)加油(you)干，為(wei)(wei)(wei)(wei)帶動通(tong)(tong)化(hua)醫藥(yao)產(chan)業(ye)升級(ji)貢獻力量(liang)，為(wei)(wei)(wei)(wei)構建(jian)和諧萬(wan)(wan)通(tong)(tong)、實力萬(wan)(wan)通(tong)(tong)、百(bai)年萬(wan)(wan)通(tong)(tong)的(de)企業(ye)愿(yuan)景而奮(fen)發(fa)有為(wei)(wei)(wei)(wei)，再創(chuang)(chuang)(chuang)輝煌(huang)。